ClinicalTrials.gg
Drug

Tenofovir clinical trials

Also written Viread, TDF and GSK548470.

studies test it
291
open now
14
in phase 3
64
first study started
1999

Counted the way a researcher would: Tenofovir with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Tenofovir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tenofovir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Oct 2001 · VIREAD · NDA 021356 (FDA, Drugs@FDA)
European Union
4 Feb 2002 · Viread · EMEA/H/C/000419 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tenofovir disoproxil fumarate
59
Tenofovir
46
Tenofovir DF
11
Tenofovir disoproxil
9
Tenofovir gel
6

Brand

Viread
50
Viread 300 mg
1
Viread 300mg
1

Development codes

GSK548470
2

Other names

TDF
21

In one entry with another drug

Given together, or one or the other

TDF/FTC
7
Tenofovir/emtricitabine
5
Emtricitabine/tenofovir
4
Emtricitabine / Tenofovir Disoproxil Oral Tablet
4
Tenofovir Disoproxil Fumarate/Emtricitabine
4
DOR/3TC/TDF
4
Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)
3
tenofovir disoproxil and emtricitabine
2

Studies by the year they started

274 studies that test it; most in 2012 (29)

Studies that test Tenofovir, by start year
YearStudies
19991
20002
20014
20022
20036
20049
20059
200610
20079
200818
200914
20108
201118
201229
20138
201411
201525
201610
201714
201817
201912
20207
20219
20224
20234
20244
20255
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
50
Phase 2
55
Phase 3
64
Phase 4
98
No phase
34

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 74 · Other 217

Gilead Sciences (28) · National Institute of Allergy and Infectious Diseases (NIAID) (18) · CONRAD (9) · ANRS, Emerging Infectious Diseases (8) · GlaxoSmithKline (8) · Bristol-Myers Squibb (8) · University of North Carolina, Chapel Hill (6) · Kirby Institute (6)

Often tested with

Tested in the same studies.

Emtricitabine (81) · Lamivudine (36) · Efavirenz (21) · Ritonavir (20) · Entecavir (16) · Atazanavir (12) · Raltegravir (11) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (9)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Tenofovir is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 5

Studies that test Tenofovir.

Studies

Open first, then newest update. How each study uses Tenofovir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 291

See all 291 studies that test Tenofovir →

Given beside what is tested · 95 — Tenofovir is usual care or a partner of the new treatment

Showing 20 of 95.

As the comparator · 63 — what is tested is compared with Tenofovir

Showing 20 of 63.

What changed recently

From the registry's own updates since Oct 18, 2026.

Results posted1

Codes

What other systems call Tenofovir · ClinicalTrials.gg INT006531

  • MeSH (NLM) D000068698TenofovirConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 99YXE507ILTENOFOVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 117466One source FDA
  • Wikidata Q106010187tenofovir hydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29490TenofovirOne source FDA

Also registered as tenofovir disoproxil (UNII F4YU4LON7I · RxNorm 300195) and tenofovir disoproxil fumarate (UNII OTT9J7900I · RxNorm 322248).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.